147 results on '"Bartlett, Nathan W."'
Search Results
2. IL-25 blockade augments antiviral immunity during respiratory virus infection
3. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
4. Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection
5. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
6. An Update in Club Cell Biology and Its Potential Relevance to Chronic Obstructive Pulmonary Disease
7. Call for Papers: “Targeting Airway Immunity in Lung Disease”
8. Call for Papers: “In It for the Long Haul: Understanding the Lasting Impact of COVID-19 on Lung Health and Disease”
9. Conditionally reprogrammed asthmatic bronchial epithelial cells express lower FOXJ1 at terminal differentiation and lower IFNs following RV-A1 infection
10. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
11. RSV-Induced Bronchial Epithelial Cell PD-L1 Expression Inhibits CD8⁺ T Cell Nonspecific Antiviral Activity
12. Understanding Rhinovirus Circulation and Impact on Illness
13. A cGAS-dependent response links DNA damage and senescence in alveolar epithelial cells: a potential drug target in IPF
14. Promoting our early career members at AJP-Lung: The Editorial Board Fellowship Program and the Next Generation Physiologist Highlights section at our Journal
15. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity
16. IL-33-Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo
17. Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirus
18. Announcing the Editorial Board Fellowship Program of the American Journal of Physiology-Lung Cellular and Molecular Physiology
19. miR-122 promotes virus-induced lung disease by targeting SOCS1
20. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
21. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs
22. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation
23. Role of deficient type III interferon-[lambda] production in asthma exacerbations
24. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
25. TLR2-mediated innate immune priming boosts lung anti-viral immunity
26. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells
27. Airway mechanical compression: its role in asthma pathogenesis and progression
28. Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD
29. The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID‐19?
30. Airway epithelial-targeted nanoparticles for asthma therapy
31. Antiviral immunity is impaired in COPD patients with frequent exacerbations
32. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
33. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
34. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
35. Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo
36. Reprogramming of lysosomal gene expression by interleukin-4 and Stat6
37. Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein
38. An Anti-Human ICAM-1 Antibody Inhibits Rhinovirus-Induced Exacerbations of Lung Inflammation
39. Correction: Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium
40. Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium
41. Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection
42. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein
43. Role of deficient type III interferon-λ production in asthma exacerbations
44. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
45. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model
46. Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence
47. A new member of the interleukin 10-related cytokine family encoded by a poxvirus
48. The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
49. Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection.
50. An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.